(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Feb 29, 2024 | (FY)Dec 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (FY)Dec 31, 2022 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | (Q4)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -505.89K | -625.62K | -284.32%-19.81K | -14.86%-441.27K | -157.43%-18.46K | 93.14%-5.15K | -384.18K | -1,321.28%-31.2K | -33.65K | 32.15K |
Net income from continuing operations | ---775.31K | ---1.01M | -509.03%-49.66K | 1.92%-510.08K | -371.76%-55.26K | 42.09%-8.15K | ---520.07K | 88.70%-20.7K | 33.94%-26.13K | --20.33K |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | --49.89K | ---- | --0 | --0 |
Other non cashItems | --16.7K | --747.88K | ---- | -88.30%11.75K | ---- | ---- | --100.47K | ---- | ---- | ---- |
Change In working capital | --252.71K | ---367.29K | 895.07%29.85K | 494.46%57.06K | 211.52%36.8K | 104.91%3K | ---14.46K | -126.94%-10.5K | -119.02%-7.52K | --11.81K |
-Change in receivables | ---329.44K | --290.78K | ---- | -256.87%-12.86K | --0 | ---- | ---3.6K | ---- | ---- | --0 |
-Change in prepaid assets | --237.97K | ---354.47K | ---- | ---91.83K | ---- | ---- | --0 | ---- | ---- | --0 |
-Change in payables and accrued expense | --344.18K | ---303.6K | 913.10%30.39K | 1,589.18%161.74K | 105.70%24.3K | 106.18%3K | ---10.86K | -175.11%-10.5K | -120.10%-7.52K | --11.81K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | ---505.89K | ---625.62K | -284.32%-19.81K | -14.86%-441.27K | -157.43%-18.46K | 93.14%-5.15K | ---384.18K | -1,321.28%-31.2K | ---33.65K | --32.15K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -281.31K | 557.38K | -12K | -109.52%-440K | 0 | -210K | ||||
Net PPE purchase and sale | ---188.38K | ---290K | ---- | -109.52%-440K | ---- | ---- | ---210K | ---- | ---- | ---- |
Net business purchase and sale | ---68.02K | --868.58K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net other investing changes | ---24.92K | ---21.2K | ---12K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---281.31K | --557.38K | ---12K | -109.52%-440K | ---- | --0 | ---210K | ---- | ---- | ---- |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 524.92K | 156.17K | 128.77%1.38M | 601.72K | 0 | -35.36K | ||||
Net issuance payments of debt | ---- | ---- | ---- | --200K | ---- | ---- | --0 | ---- | --0 | ---- |
Net common stock issuance | --0 | --260K | ---- | 93.97%1.17M | ---- | ---- | --601.72K | ---- | ---- | --0 |
Net other financing activities | --24.92K | ---103.83K | ---- | --9.4K | ---- | ---- | ---- | ---- | ---- | ---35.36K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --524.92K | --156.17K | ---- | 128.77%1.38M | ---- | ---- | --601.72K | ---- | --0 | ---35.36K |
Net cash flow | ||||||||||
Beginning cash position | --590.76K | --502.83K | -28.29%694.93K | --7.54K | -7.06%963.88K | -12.87%969.03K | --0 | 319.10%1M | 333.20%1.03M | --1.04M |
Current changes in cash | ---262.29K | --87.93K | -517.15%-31.81K | 6,467.99%495.29K | -475.17%-18.46K | 93.14%-5.15K | --7.54K | ---31.2K | ---33.65K | ---3.21K |
End cash Position | --328.47K | --590.76K | -31.20%663.13K | 6,567.99%502.83K | -8.56%945.41K | -7.06%963.88K | --7.54K | -12.87%969.03K | 319.10%1M | --1.03M |
Free cash from | ---694.27K | ---915.62K | -284.32%-19.81K | -48.32%-881.27K | -157.43%-18.46K | 93.14%-5.15K | ---594.18K | -1,321.28%-31.2K | ---33.65K | --32.15K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data